Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

March 27, 2026

Ver artículo completo

Successful Treatment of Acquired Idiopathic Generalized Anhidrosis With Baricitinib

Puntos clave

To report the effectiveness of baricitinib in treating acquired idiopathic generalized anhidrosis in patients.
Described two cases of patients with acquired idiopathic generalized anhidrosis.
Administered baricitinib for treatment.
Both patients showed improvement in symptoms after treatment with baricitinib.

Resumen

This case report describes 2 otherwise healthy patients who presented with acquired idiopathic generalized anhidrosis and were treated with baricitinib.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Chang et al. (Wed,) studied this question.

synapsesocial.com/papers/69c620d515a0a509bde197ff https://doi.org/https://doi.org/10.1001/jamadermatol.2026.0010

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Acquired Idiopathic Generalized Anhidrosis and Frontal Fibrosing Alopecia: Possible Evidence for a Shared Autoimmune Pathogenesis2025 · 1 citations
2JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies2018 · 527 citations
3Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis2020 · 279 citations
4Revised guideline for the diagnosis and treatment of acquired idiopathic generalized anhidrosis in Japan2016 · 83 citations
5Multiple courses of steroid pulse therapy are required in treating acquired idiopathic generalized anhidrosis patients with a large anhidrotic area: A retrospective study of 28 cases2023 · 3 citations

Tratamiento exitoso de la anhidrosis generalizada idiopática adquirida con baricitinib | Synapse